Transcode Therapeutics, Inc. (RNAZ)
↓ Download CSVKey ratios (FY2025)
-335.4%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$27.98M | -$15.66M | -$19.42M | -$18.63M | -$6.15M | -$726.6K | — |
| Net Income | -$34.66M | -$16.75M | -$18.55M | -$17.56M | -$6.84M | -$2.34M | — |
| EPS (Diluted) | $-52.59 | $-1336.63 | $-3419.01 | $-1082.79 | $-0.81 | $-0.51 | — |
| Total Assets | $162.40M | $7.29M | $5.17M | $7.59M | $22.94M | $1.06M | — |
| Total Liabilities | $10.52M | $9.31M | $3.53M | $4.35M | $2.53M | $4.46M | — |
| Shareholders' Equity | $10.34M | -$2.02M | $1.64M | $3.24M | $20.40M | -$3.41M | -$1.11M |
| Cash & Equivalents | $17.81M | $5.81M | $2.77M | $4.97M | $20.83M | $828.0K | — |
| Operating Cash Flow | -$19.52M | -$13.34M | -$18.07M | -$15.76M | -$5.27M | -$493.0K | — |
| Capital Expenditures | $6.7K | $21.8K | $35.6K | $100.9K | $254.8K | — | — |
| Shares Outstanding | 917.0K | 36.8K | 19.0K | 16.2K | 12.90M | 4.64M | — |